The most crucial objective was to determine suited analytical targets by analyzing human hepatocyte incubation samples with high-resolution mass spectrometry (HRMS) and to verify the effects in genuine urine specimens and to determine AB-FUBINACA's metabolic stability in human liver microsomes and in contrast hepatocyte and urine success with in silico https://geraldz950qgv4.newsbloger.com/profile